The global Next-Generation Sequencing Services Market is expanding rapidly, driven by the declining cost of genetic sequencing, the growing adoption of precision medicine, increasing demand for advanced genomic research, and the outsourcing of complex sequencing workflows. Next-generation sequencing enables researchers and healthcare professionals to analyze DNA and RNA at high throughput, supporting applications in oncology, rare disease diagnosis, drug discovery, and personalized healthcare.

Market Size and Growth Forecasts

The global NGS services market is positioned for substantial growth as sequencing technologies become increasingly accessible across healthcare, biotechnology, pharmaceutical, and academic research settings.

• 2025 Market Valuation: USD 8.0 billion.

• 2026 Market Valuation: USD 9.6 billion.

• Projected Market Valuation (2033): USD 40.4 billion.

• Growth Rate: CAGR of 22.9% during the forecast period (2026–2033).

The market's expansion reflects the growing importance of genomic information in modern healthcare and life sciences research. Pharmaceutical companies are increasingly using sequencing services to identify therapeutic targets, discover biomarkers, and support clinical trials. Meanwhile, healthcare providers are adopting genomic testing to improve disease diagnosis and inform personalized treatment strategies. These developments are creating opportunities for specialized sequencing service providers worldwide.

Download a free sample copy of the Next-generation Sequencing Services Market report to understand detailed coverage and inclusions in the final report

Key Drivers and Industry Trends

• Declining Sequencing Costs and Technological Advancements: Improvements in sequencing chemistry, laboratory automation, and high-throughput platforms are making genomic analysis more accessible. Lower operational barriers encourage hospitals, research institutions, and biotechnology companies to outsource sequencing rather than establish and maintain expensive in-house infrastructure. These developments are supporting broader adoption across research and clinical applications.

• AI and Cloud-Based Genomic Analytics: Artificial intelligence and cloud computing are transforming how sequencing data is processed and interpreted. Advanced bioinformatics tools help researchers analyze large genomic datasets, identify genetic variants, and investigate disease-associated mutations. Growing demand for data interpretation, multi-omics research, and scalable storage is creating additional opportunities for NGS service providers.

• Growing Demand for Precision Medicine: Precision medicine relies on molecular and genetic information to guide disease diagnosis and treatment selection. NGS supports the identification of disease-associated variants, cancer-related mutations, and potential therapeutic biomarkers. Its applications in oncology, inherited disorders, and pharmacogenomics are strengthening demand for specialized sequencing services.

• Biopharmaceutical Outsourcing: Pharmaceutical and biotechnology companies increasingly collaborate with external sequencing providers to support drug discovery, biomarker identification, translational research, and clinical development. Outsourcing gives organizations access to advanced sequencing platforms and specialist expertise without requiring equivalent investments in laboratory infrastructure.

• Expansion of Clinical Genomics: Increasing interest in rare disease diagnosis, cancer profiling, and infectious disease research is encouraging healthcare organizations to integrate genomic testing into diagnostic workflows. As clinical applications expand, service providers are investing in reliable laboratory processes, data interpretation capabilities, and quality management systems.

Geographic Dynamics

• North America: North America dominated the global NGS services market with a 45.3% revenue share in 2025, according to Grand View Research. Its leadership is supported by established genomics infrastructure, advanced clinical laboratories, strong research investment, and the presence of major sequencing technology and service companies. The United States remains an important contributor to regional demand, particularly in precision medicine, oncology, and pharmaceutical research.

• Asia Pacific: Asia Pacific is projected to be the fastest-growing regional market, with a forecast CAGR of 24.4% from 2026 to 2033. Growth is supported by expanding healthcare infrastructure, investments in genomic research, increasing demand for advanced diagnostics, and precision medicine initiatives across China, India, and Japan. The development of regional sequencing laboratories and collaborations between research institutions and technology providers is expected to further support market expansion.

• Europe: Europe is expected to experience continued growth, supported by biomedical research funding, established healthcare systems, genomic medicine initiatives, and collaborations between academic institutions and pharmaceutical companies. The United Kingdom and Germany are among the important markets for research and clinical genomics.

Go Deeper! Ask Prism AI

about the Global Next-Generation Sequencing Services Market. Get instant answers to

questions related to market sizing, growth drivers & their impact, and more.

Prominent Industry Players

The competitive landscape includes sequencing platform manufacturers, specialist genomic laboratories, and providers of integrated sequencing and bioinformatics services. Major companies identified in the Grand View Research report include:

• Illumina, Inc.

• Thermo Fisher Scientific Inc.

• BGI Genomics

• Eurofins Genomics

• GENEWIZ

• Macrogen Inc.

• QIAGEN N.V.

• Agilent Technologies Inc.

• Revvity, Inc.

• Twist Bioscience

These companies compete through technological innovation, sequencing capacity, service quality, data analysis capabilities, strategic partnerships, and expansion into new applications. Their offerings support whole-genome sequencing, targeted sequencing, transcriptomics, and other genomic research requirements.

Looking for more specific insights? Customize this report to suite your business needs